Post Content
Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in. On December 1, Morgan Stanley assumed coverage of Grail with an Equal Weight rating and a price target of $110, which was up from $85. Heading into 2026, the firm is optimistic about the Life Science space, noting several emerging growth drivers. While the firm likes the industry’s long-term setup, it argued that a recent valuation spike has left stock prices at a reasonable equilibrium.
In Q3 2025, Grail highlighted a 26% year-over-year revenue increase to $36.2 million. This growth was driven by the Galleri multi-cancer early detection test, which saw screening revenue rise 29% to $32.8 million. The company sold over 45,000 Galleri tests during the quarter, representing a 39% increase in volume compared to the prior year. Efficiency gains from its high-throughput platform also helped improve non-GAAP adjusted gross margins to 55%, a significant jump from 41% in Q3 2024. Despite the revenue growth, Grail reported a net loss of $89 million for the quarter, though this was a 29% improvement over the previous year.
Clinical milestones during the quarter included positive data from the PATHFINDER 2 and SYMPLIFY studies. Results showed that adding Galleri to standard screenings led to a sevenfold increase in cancer detection rates with a high specificity of 99.6%. Furthermore, long-term follow-up from the SYMPLIFY study increased the test’s positive predictive value to 84.2%, as many initial false positives were later diagnosed with cancer at the site predicted by Galleri. The company also announced a new partnership with Samsung to commercialize the test in South Korea, Japan, and Singapore.
Grail Inc. (NASDAQ:GRAL) is a commercial-stage healthcare company that provides multi-cancer early detection testing and services in the US and internationally.
While we acknowledge the potential of GRAL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.